Harrow (HROW) Other Non-Current Assets (2017 - 2021)
Harrow (HROW) posted quarterly Other Non-Current Assets of $200000.0 for Q3 2021, little changed year-over-year from $200000.0 in Q3 2020, and little changed quarter-over-quarter from $200000.0 in Q2 2021.
Harrow (HROW) Other Non-Current Assets (2017 - 2021) Analysis & Trends
Harrow's Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $200000.0 for Q3 2021.
- In Q3 2021, Other Non-Current Assets changed 0.0% year-over-year to $200000.0; the TTM figure through Sep 2021 stood at $200000.0 (changed 0.0% YoY), while the FY2020 annual figure was $200000.0, changed 0.0% from the prior year.
- Other Non-Current Assets for Q3 2021 stood at $200000.0, roughly flat from $200000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $631000.0 in Q2 2017, with the low at $200000.0 in Q4 2017.
- The 5-year median for Other Non-Current Assets is $200000.0 (2017), against an average of $247888.9.
- Peak annual rise in Other Non-Current Assets reached 0.0% in 2018, while the deepest fall reached 68.3% in 2018.
- Harrow's Other Non-Current Assets stood at $200000.0 in 2017, then changed by 0.0% to $200000.0 in 2018, then changed by 0.0% to $200000.0 in 2019, then changed by 0.0% to $200000.0 in 2020, then changed by 0.0% to $200000.0 in 2021.
- Business Quant data shows HROW's Other Non-Current Assets at $200000.0 in Q3 2021, $200000.0 in Q2 2021, and $200000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 13.00 Mn |
| 10 | Harrow | 1.58 Bn | 1.49 Bn | 50.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 200,000.00 |
| Mar 31, 2021 | 200,000.00 |
| Dec 31, 2020 | 200,000.00 |
| Sep 30, 2020 | 200,000.00 |
| Jun 30, 2020 | 200,000.00 |
| Mar 31, 2020 | 200,000.00 |
| Dec 31, 2019 | 200,000.00 |
| Sep 30, 2019 | 200,000.00 |
| Jun 30, 2019 | 200,000.00 |
| Mar 31, 2019 | 200,000.00 |
| Dec 31, 2018 | 200,000.00 |
| Sep 30, 2018 | 200,000.00 |
| Jun 30, 2018 | 200,000.00 |
| Mar 31, 2018 | 200,000.00 |
| Dec 31, 2017 | 200,000.00 |
| Sep 30, 2017 | 631,000.00 |
| Jun 30, 2017 | 631,000.00 |